Inhibitors, what is the risk of treatment intensity?
Collins
P W
PW
Department of Haematology, University Hospital of Wales, Arthur Bloom Haemophilia Centre, Cardiff, UK. peter.collins@cardiffandvale.wales.nhs.uk
D004342:Drug Hypersensitivity / Q000209:etiology / Q000276:immunology; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D008297:Male; D012307:Risk Factors
D007518:Isoantibodies; D005169:Factor VIII